Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3501)
All Articles published online
|
Jun 15, 2003 (publication date) through Feb 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zheng S, Han MY, Xiao ZX, Peng JP, Dong Q. Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World J Gastroenterol 2003; 9(6): 1227-1230 [PMID: 12800229 DOI: 10.3748/wjg.v9.i6.1227] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i6/1227.htm |
| Number | Citing Articles |
| 1 |
Yibaina Wang, Xiaoping Yao, Jie Ge, Fulan Hu, Yashuang Zhao. Can Vascular Endothelial Growth Factor and Microvessel Density Be Used as Prognostic Biomarkers for Colorectal Cancer? A Systematic Review and Meta-Analysis. The Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/102736
|
| 2 |
Carolyn A Staton, Ivan Koay, Jessie M Wu, Leslie Hoh, Malcolm W R Reed, Nicola J Brown. Neuropilin‐1 and neuropilin‐2 expression in the adenoma–carcinoma sequence of colorectal cancer. Histopathology 2013; 62(6): 908 doi: 10.1111/his.12098
|
| 3 |
Adrian M. Jubb, Herbert I. Hurwitz, Wei Bai, Eric B. Holmgren, Patti Tobin, A. Steven Guerrero, Fairooz Kabbinavar, Scott N. Holden, William F. Novotny, Gretchen D. Frantz, Kenneth J. Hillan, Hartmut Koeppen. Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer. Journal of Clinical Oncology 2006; 24(2): 217 doi: 10.1200/JCO.2005.01.5388
|
| 4 |
R. Longo, G. Gasparini. Challenges for patient selection with VEGF inhibitors. Cancer Chemotherapy and Pharmacology 2007; 60(2): 151 doi: 10.1007/s00280-006-0403-6
|
| 5 |
M. José Ortiz-Morales, Marta Toledano-Fonseca, Rafael Mena-Osuna, M. Teresa Cano, Auxiliadora Gómez-España, Juan R. De la Haba-Rodríguez, Antonio Rodríguez-Ariza, Enrique Aranda. Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab. Cancers 2022; 14(13): 3054 doi: 10.3390/cancers14133054
|
| 6 |
Mark Ellrichmann, Peter R. Ritter, Henning Schrader, Wolfgang E. Schmidt, Juris J. Meier, Frank Schmitz. Gastrin stimulates the VEGF-A promotor in a human colon cancer cell line. Regulatory Peptides 2010; 165(2-3): 146 doi: 10.1016/j.regpep.2010.06.004
|
| 7 |
Coen I. M. Baeten. Inflammation and Cancer. Methods in Molecular Biology 2009; 511: 61 doi: 10.1007/978-1-59745-447-6_2
|
| 8 |
A M Jubb, H Turley, H C Moeller, G Steers, C Han, J-L Li, R Leek, E Y Tan, B Singh, N J Mortensen, I Noguera-Troise, F Pezzella, K C Gatter, G Thurston, S B Fox, A L Harris. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer. British Journal of Cancer 2009; 101(10): 1749 doi: 10.1038/sj.bjc.6605368
|
| 9 |
Biljana Ljujic, Gordana Radosavljevic, Ivan Jovanovic, Sladjana Pavlovic, Nemanja Zdravkovic, Marija Milovanovic, Ljubisa Acimovic, Milan Knezevic, Dragic Bankovic, Dusica Zdravkovic, Nebojsa Arsenijevic. Elevated Serum Level of IL-23 Correlates with Expression of VEGF in Human Colorectal Carcinoma. Archives of Medical Research 2010; 41(3): 182 doi: 10.1016/j.arcmed.2010.02.009
|
| 10 |
Agnieszka Michael, Kate Relph, Hardev Pandha. Emergence of potential biomarkers of response to anti‐angiogenic anti‐tumour agents. International Journal of Cancer 2010; 127(6): 1251 doi: 10.1002/ijc.25389
|
| 11 |
Luciana Regina Moreira, André Almeida Schenka, Paulo Latuf-Filho, André Lisboa Penná, Carmen S. P. Lima, Fernando Augusto Soares, Miriam Aparecida Silva Trevisan, José Vassallo. Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors. Tumor Biology 2011; 32(3): 527 doi: 10.1007/s13277-010-0147-0
|
| 12 |
Paola Tonino, Carmen Abreu. Microvessel Density Is Associated with VEGF and α-SMA Expression in Different Regions of Human Gastrointestinal Carcinomas. Cancers 2011; 3(3): 3405 doi: 10.3390/cancers3033405
|
| 13 |
Malin Sund, Michael Zeisberg, Raghu Kalluri. Endogenous Stimulators and Inhibitors of Angiogenesis in Gastrointestinal Cancers: Basic Science to Clinical Application. Gastroenterology 2005; 129(6): 2076 doi: 10.1053/j.gastro.2005.06.023
|
| 14 |
Hyuk‐Chan Kwon, Sung Hyun Kim, Sung Yong Oh, Suee Lee, Kyung A Kwon, Jong Hoon Lee, Hong‐Jo Choi, Ki‐Jae Park, Hyung‐Sik Lee, Mee Sook Roh, Hyo‐Jin Kim. Clinicopathological significance of nuclear factor‐kappa B, HIF‐1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer. Cancer Science 2010; 101(6): 1557 doi: 10.1111/j.1349-7006.2010.01553.x
|
| 15 |
Leandro Mutschall, Paulo Condeixa de França, Leslie Ecker Ferreira, Hercilio Fronza Jr., Rodrigo Blasios, Mauro Pinho. Análise da relação entre a expressão da proteína VEGF e o estadiamento do câncer colorretal. Revista Brasileira de Coloproctologia 2009; 29(1): 15 doi: 10.1590/S0101-98802009000100002
|
| 16 |
Ajay Malik, RN Mishra, B Fanthome, Ramesh Rao, SR Patrikar. Role of CD34, vascular endothelial growth factor, and p53 in neoangiogenesis as correlated with stage of disease in colorectal carcinoma. Medical Journal Armed Forces India 2011; 67(4): 320 doi: 10.1016/S0377-1237(11)60076-2
|
| 17 |
Justyna Zygoń, Mariusz Szajewski, Wiesław Janusz Kruszewski, Robert Rzepko. VEGF, Flt-1, and microvessel density in primary tumors as predictive factors of colorectal cancer prognosis. Molecular and Clinical Oncology 2017; 6(2): 243 doi: 10.3892/mco.2016.1121
|
| 18 |
Roberto Dinami, Manuela Porru, Carla Azzurra Amoreo, Isabella Sperduti, Marcella Mottolese, Simonetta Buglioni, Daniele Marinelli, Marcello Maugeri-Saccà, Andrea Sacconi, Giovanni Blandino, Carlo Leonetti, Giuliana Di Rocco, Alessandra Verdina, Francesca Spinella, Francesco Fiorentino, Gennaro Ciliberto, Annamaria Biroccio, Pasquale Zizza. TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01612-z
|
| 19 |
Shuji Iida, Hirotoshi Hasegawa, Koji Okabayashi, Konosuke Moritani, Makio Mukai, Yuko Kitagawa. Risk Factors for Postoperative Recurrence in Patients with Pathologically T1 Colorectal Cancer. World Journal of Surgery 2012; 36(2): 424 doi: 10.1007/s00268-011-1378-y
|
| 20 |
André Goulart, Carla Ferreira, Ana Rodrigues, Barbara Coimbra, Nuno Sousa, Pedro Leão. The correlation between serum vascular endothelial growth factor (VEGF) and tumor VEGF receptor 3 in colorectal cancer. Annals of Surgical Treatment and Research 2019; 97(1): 15 doi: 10.4174/astr.2019.97.1.15
|
| 21 |
M. Ashraf Balbaa, Noha Elkady, Emad M. Abdelrahman. Predictive Factors of Positive Circumferential and Longitudinal Margins in Early T3 Colorectal Cancer Resection. International Journal of Surgical Oncology 2020; 2020: 1 doi: 10.1155/2020/6789709
|
| 22 |
Eleonora Lai, Nicole Liscia, Clelia Donisi, Stefano Mariani, Simona Tolu, Andrea Pretta, Mara Persano, Giovanna Pinna, Francesca Balconi, Annagrazia Pireddu, Valentino Impera, Marco Dubois, Marco Migliari, Dario Spanu, Giorgio Saba, Silvia Camera, Francesca Musio, Pina Ziranu, Marco Puzzoni, Laura Demurtas, Valeria Pusceddu, Manuela Dettori, Elena Massa, Francesco Atzori, Mariele Dessì, Giorgio Astara, Clelia Madeddu, Mario Scartozzi. Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer. Cancers 2020; 12(5): 1214 doi: 10.3390/cancers12051214
|
| 23 |
Alexandra Giatromanolaki, Efthimios Sivridis, Michael I. Koukourakis. Angiogenesis in Colorectal Cancer: Prognostic and Therapeutic Implications. American Journal of Clinical Oncology 2006; 29(4): 408 doi: 10.1097/01.coc.0000221317.56731.4e
|
| 24 |
YUTAKA KIMURA, SATOKO MOROHASHI, TADASHI YOSHIZAWA, TAKAHIRO SUZUKI, HAJIME MOROHASHI, YOSHIYUKI SAKAMOTO, MOTOI KOYAMA, AKIHIKO MURATA, HIROSHI KIJIMA, KENICHI HAKAMADA. Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer. Molecular Medicine Reports 2016; 13(2): 1551 doi: 10.3892/mmr.2015.4687
|
| 25 |
Kyriakos Zafirellis, George Agrogiannis, Aglaia Zachaki, Katerina Gravani, Andreas Karameris, Christos Kombouras. Prognostic Significance of VEGF Expression Evaluated by Quantitative Immunohistochemical Analysis in Colorectal Cancer. Journal of Surgical Research 2008; 147(1): 99 doi: 10.1016/j.jss.2007.05.041
|
| 26 |
Joon-Yong Chung, Till Braunschweig, Seung-Mo Hong, David S Kwon, Soo-Heang Eo, HyungJun Cho, Stephen M Hewitt. Assessment of vascular endothelial growth factor in formalin fixed, paraffin embedded colon cancer specimens by means of a well-based reverse phase protein array. Proteome Science 2014; 12(1) doi: 10.1186/1477-5956-12-27
|
| 27 |
G Des Guetz, B Uzzan, P Nicolas, M Cucherat, J-F Morere, R Benamouzig, J-L Breau, G-Y Perret. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. British Journal of Cancer 2006; 94(12): 1823 doi: 10.1038/sj.bjc.6603176
|
| 28 |
George Emmanouil, George Ayiomamitis, Adamantia Zizi-Sermpetzoglou, Maria Tzardi, Andrew Moursellas, Argyro Voumvouraki, Elias Kouroumalis. Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations. Analytical Cellular Pathology 2018; 2018: 1 doi: 10.1155/2018/1616973
|
| 29 |
I.A. Bogomolova, D.R. Dolgova, I.I. Antoneeva, T.P. Gening, T.I. Kuznetsova. EXPRESSION OF VASCULOENDOTHELIAL AND PLATE GROWTH FACTORS IN PRIMARY COLORECTAL TUMOR AS A PREDICTOR OF EARLY RECURRENCE. Ulyanovsk Medico-biological Journal 2020; (4): 74 doi: 10.34014/2227-1848-2020-4-74-86
|
| 30 |
Flavia Longo, Giovanni Mansueto. Bevacizumab in Associazione Con La Chemioterapia Nel Trattamento Dei Tumori Solidi: Novitá Dall'Asco 2005. Tumori Journal 2005; 91(4): 1 doi: 10.1177/030089160509100425
|
| 31 |
Ke-Jun Nan, Hai-Xia Qin, Guang Yang. Prognostic factors in 165 elderly colorectal cancer patients. World Journal of Gastroenterology 2003; 9(10): 2207-2210 doi: 10.3748/wjg.v9.i10.2207
|
| 32 |
Sahande Elagoz, Reyhan Egilmez, Ayhan Koyuncu, Ahmet Muslehiddinoglu, Sema Arici. The intratumoral microvessel density and expression of bFGF and nm23-Hl in colorectal cancer. Pathology & Oncology Research 2006; 12(1): 21 doi: 10.1007/BF02893427
|
| 33 |
Saulius Svagzdys, Vaiva Lesauskaite, Dainius Pavalkis, Irena Nedzelskienė, Darius Pranys, Algimantas Tamelis. Microvessel density as new prognostic marker after radiotherapy in rectal cancer. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-95
|
| 34 |
Coen I.M. Baeten, Karolien Castermans, Harry F.P. Hillen, Arjan W. Griffioen. Proliferating Endothelial Cells and Leukocyte Infiltration as Prognostic Markers in Colorectal Cancer. Clinical Gastroenterology and Hepatology 2006; 4(11): 1351 doi: 10.1016/j.cgh.2006.08.005
|
| 35 |
Tadahiro Nozoe, Emiko Mori, Ikuo Takahashi, Takahiro Ezaki. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surgery Today 2008; 38(7): 597 doi: 10.1007/s00595-007-3680-8
|
| 36 |
Edmundo Guilherme de Almeida Gomes, Mário Jorge Jucá, Hunaldo Lima de Menezes, Benício Luiz Bulhões Barros Paula Nunes, Henrique Costa, Flávio de Oliveira Lima, Delcio Matos. Correlation between the immunohistochemical expressions of MMP-1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma. Acta Cirurgica Brasileira 2009; 24(4): 303 doi: 10.1590/S0102-86502009000400010
|
| 37 |
Hemant K. Roy, Ramesh K. Wali, Young Kim, Yang Liu, John Hart, Dhananjay P. Kunte, Jennifer L. Koetsier, Michael J. Goldberg, Vadim Backman. Inducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis. FEBS Letters 2007; 581(20): 3857 doi: 10.1016/j.febslet.2007.07.012
|
| 38 |
Nyree Griffin, Vicky Goh. Functional imaging of the bowel. Abdominal Imaging 2013; 38(6): 1203 doi: 10.1007/s00261-013-0030-8
|
| 39 |
Khaled Abdel-Hakim, Nagwa El-Nefiawy. Liver angiogenesis: tumor host interaction in non-metastatic colorectal cancer. The Chinese-German Journal of Clinical Oncology 2011; 10(10): 575 doi: 10.1007/s10330-011-0858-8
|
| 40 |
Longhai Li, Kai Jiang, Dongpeng Li, Dongxiao Li, Zitong Fan, Guosheng Dai, Sheng Tu, Xiangyu Liu, Guangyou Wei. The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.754221
|
| 41 |
Shao-Hua Peng, Hong Deng, Jian-Feng Yang, Ping-Ping Xie, Cheng Li, Hao Li, De-Yun Feng. Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World Journal of Gastroenterology 2005; 11(41): 6521-6524 doi: 10.3748/wjg.v11.i41.6521
|
| 42 |
Diana L. Hanna, Fotios Loupakis, Dongyun Yang, Chiara Cremolini, Marta Schirripa, Meng Li, Satoshi Matsusaka, Martin D. Berger, Yuji Miyamoto, Wu Zhang, Yan Ning, Carlotta Antoniotti, Lisa Salvatore, Miriana Moran, Gary Zeger, Stephanie H. Astrow, Alfredo Falcone, Heinz-Josef Lenz. Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. Clinical Colorectal Cancer 2018; 17(3): e471 doi: 10.1016/j.clcc.2018.03.006
|
| 43 |
Motohiro Yamamori, Toshiyuki Sakaeda, Tsutomu Nakamura, Noboru Okamura, Takao Tamura, Nobuo Aoyama, Takashi Kamigaki, Masakazu Ohno, Toshiro Shirakawa, Akinobu Gotoh, Yoshikazu Kuroda, Masafumi Matsuo, Masato Kasuga, Katsuhiko Okumura. Association of VEGF genotype with mRNA level in colorectal adenocarcinomas. Biochemical and Biophysical Research Communications 2004; 325(1): 144 doi: 10.1016/j.bbrc.2004.10.005
|
| 44 |
Ye-Jiang Zhou, Yu-Xia Xiong, Xiao-Ting Wu, De Shi, Wei Fan, Tong Zhou, Yue-Chun Li, Xiong Huang. Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer. World Journal of Gastroenterology 2004; 10(21): 3225-3229 doi: 10.3748/wjg.v10.i21.3225
|
| 45 |
M.F. Acikalin, Ü. Öner, İ. Topçu, B. Yaşar, H. Kiper, E. Çolak. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Digestive and Liver Disease 2005; 37(3): 162 doi: 10.1016/j.dld.2004.09.028
|
| 46 |
Inês Mazeda, Sandra F. Martins, Eduardo A. Garcia, Mesquita Rodrigues, Adhemar Longatto. VEGF Expression in Colorectal Cancer Metastatic Lymph Nodes: Clinicopathological Correlation and Prognostic Significance. Gastrointestinal Disorders 2020; 2(3): 267 doi: 10.3390/gidisord2030025
|
| 47 |
Wei Lv, Chao Zhang, Ding-Hua Zhou, Jia Hao, Jian-Guo Sun, Tao Liu, Ying-Xue Hao, Pei-Wu Yu. RNAi-Mediated Gene Silencing of Vascular Endothelial Growth Factor Inhibits Growth of Colorectal Cancer. Cancer Biotherapy and Radiopharmaceuticals 2007; 22(6): 841 doi: 10.1089/cbr.2007.0409
|
| 48 |
Chao Yan, Zheng-Gang Zhu, Ying-Yan Yu, Jun Ji, Yi Zhang, Yu-Bao Ji, Min Yan, Jun Chen, Bing-Ya Liu, Hao-Ran Yin, Yan-Zhen Lin. Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis. World Journal of Gastroenterology 2004; 10(6): 783-790 doi: 10.3748/wjg.v10.i6.783
|
| 49 |
Matthieu Camus, Marie Tosolini, Bernhard Mlecnik, Franck Pagès, Amos Kirilovsky, Anne Berger, Anne Costes, Gabriela Bindea, Pornpimol Charoentong, Patrick Bruneval, Zlatko Trajanoski, Wolf-Herman Fridman, Jérôme Galon. Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence. Cancer Research 2009; 69(6): 2685 doi: 10.1158/0008-5472.CAN-08-2654
|
| 50 |
Daniele Minardi, Matteo Santoni, Guendalina Lucarini, Roberta Mazzucchelli, Luciano Burattini, Alessandro Conti, Maristella Bianconi, Mario Scartozzi, Giulio Milanese, Roberto Di Primio, Rodolfo Montironi, Stefano Cascinu, Giovanni Muzzonigro. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations 2015; 33(3): 113.e1 doi: 10.1016/j.urolonc.2014.06.014
|
| 51 |
Betul Bolat Kucukzeybek, Yelda Dere, Aysegul Akder Sari, Irfan Ocal, Emel Avcu, Ozcan Dere, Aylin Orgen Calli, Cigdem Dinckal, Mine Tunakan, Yuksel Kucukzeybek. The prognostic significance of CD117-positive mast cells and microvessel density in colorectal cancer. Medicine 2024; 103(29): e38997 doi: 10.1097/MD.0000000000038997
|
| 52 |
F. Mehrkhani, S. Nasiri, K. Donboli, A. Meysamie, A. Hedayat. Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Disease 2009; 11(2): 157 doi: 10.1111/j.1463-1318.2008.01556.x
|
| 53 |
Maressa A. Bruhn, Amanda R. Townsend, Chee Khoon Lee, Aravind Shivasami, Timothy J. Price, Joe Wrin, Georgia Arentz, Niall C. Tebbutt, Christopher Hocking, David Cunningham, Jennifer E. Hardingham. Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer. International Journal of Cancer 2014; 135(3): 731 doi: 10.1002/ijc.28698
|
| 54 |
Yanislav Kolev, Hiroyuki Uetake, Satoru Iida, Toshiaki Ishikawa, Tatsuyuki Kawano, Kenichi Sugihara. Prognostic Significance of VEGF Expression in Correlation With COX-2, Microvessel Density, and Clinicopathological Characteristics in Human Gastric Carcinoma. Annals of Surgical Oncology 2007; 14(10): 2738 doi: 10.1245/s10434-007-9484-7
|
| 55 |
Subalakshmi Balasubramanian, Nagarajan Priyathersini, Thanka Johnson. Expression of Vascular Endothelial Growth Factor (VEGF) in Colorectal Adenoma and Carcinoma in a Tertiary Care Center. Cureus 2022; doi: 10.7759/cureus.31393
|
| 56 |
A. Giatromanolaki, M. I. Koukourakis, E. Sivridis, G. Chlouverakis, E. Vourvouhaki, H. Turley, A. L. Harris, K. C. Gatter. Activated Vegfr2/kdr Pathway In Tumour Cells And Tumour Associated Vessels Of Colorectal Cancer. European Journal of Clinical Investigation 2007; 37(11): 878 doi: 10.1111/j.1365-2362.2007.01866.x
|
| 57 |
Asmaa Hussein Mohamed, Nelly Mohamed Said. Immunohistochemical Expression of Fatty Acid Synthase and Vascular Endothelial Growth Factor in Primary Colorectal Cancer: a Clinicopathological Study. Journal of Gastrointestinal Cancer 2019; 50(3): 485 doi: 10.1007/s12029-018-0104-5
|
| 58 |
Priti S. Hegde, Adrian M. Jubb, Dafeng Chen, Nicole F. Li, Y. Gloria Meng, Coen Bernaards, Rebecca Elliott, Stefan J. Scherer, Daniel S. Chen. Predictive Impact of Circulating Vascular Endothelial Growth Factor in Four Phase III Trials Evaluating Bevacizumab. Clinical Cancer Research 2013; 19(4): 929 doi: 10.1158/1078-0432.CCR-12-2535
|
| 59 |
Hsiang-Lin Tsai, I-Ping Yang, Chih-Hung Lin, Chee-Yin Chai, Yu-Ho Huang, Chin-Fan Chen, Ming-Feng Hou, Chao-Hung Kuo, Suh-Hang Juo, Jaw-Yuan Wang. Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection. International Journal of Colorectal Disease 2013; 28(3): 415 doi: 10.1007/s00384-012-1570-z
|
| 60 |
Ming-yong Han, Jin-ming Yu, Shu Zheng, Qi-sen Guo, Jia-lin Wang, Jia-ping Peng, Qi Dong. Serum interleukin-18 level as a prognostic marker in patients with colorectal carcinoma. Chinese Journal of Cancer Research 2004; 16(2): 127 doi: 10.1007/s11670-004-0011-0
|
| 61 |
Khadijeh Barzaman, Mitra Samadi, Shima Moradi-kalbolandi, Keivan Majidzadeh-A, Malihe Salehi, Neda Jalili, Mir hadi Jazayeri, Samaneh Khorammi, Behrad Darvishi, Vahid Siavashi, Mahdi Shekarabi, Leila Farahmand. Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency. Experimental Cell Research 2021; 405(2): 112685 doi: 10.1016/j.yexcr.2021.112685
|
| 62 |
Ann-Margaret Ochs, Lucas Wong, Vijaya Kakani, Srilatha Neerukonda, Julie Gorske, Arundhati Rao, Mark Riggs, Heather Ward, Lisa Keville. Expression of Vascular Endothelial Growth Factor and HER2/neu in Stage II Colon Cancer and Correlation with Survival. Clinical Colorectal Cancer 2004; 4(4): 262 doi: 10.3816/CCC.2004.n.025
|
| 63 |
Magdy A.-H. Zahran, Tarek A.-R. Salem, Rehab M. Samaka, Hussein S. Agwa, Ayman R. Awad. Design, synthesis and antitumor evaluation of novel thalidomide dithiocarbamate and dithioate analogs against Ehrlich ascites carcinoma-induced solid tumor in Swiss albino mice. Bioorganic & Medicinal Chemistry 2008; 16(22): 9708 doi: 10.1016/j.bmc.2008.09.071
|
| 64 |
M Verstraete, A Debucquoy, J Dekervel, J van Pelt, C Verslype, E Devos, G Chiritescu, K Dumon, A D'Hoore, O Gevaert, X Sagaert, E Van Cutsem, K Haustermans. Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial. British Journal of Cancer 2015; 112(8): 1314 doi: 10.1038/bjc.2015.93
|
| 65 |
Lukas J.A.C. Hawinkels, Kim Zuidwijk, Hein W. Verspaget, Eveline S.M. de Jonge-Muller, Wim van Duijn, Valérie Ferreira, Ruud D. Fontijn, Guido David, Daniel W. Hommes, Cornelis B.H.W. Lamers, Cornelis F.M. Sier. VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. European Journal of Cancer 2008; 44(13): 1904 doi: 10.1016/j.ejca.2008.06.031
|
| 66 |
Hélène Poels, Pieter-Jan Cuyle, Eric Van Cutsem. Multidisciplinary Management of Rectal Cancer. 2018; : 273 doi: 10.1007/978-3-319-43217-5_36
|
| 67 |
Eleonora Lai, Stefano Cascinu, Mario Scartozzi. Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.637823
|
| 68 |
Han-Ping Wu, Gan-Sheng Feng, Hui-Min Liang, Chuan-Sheng Zheng, Xin Li. Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats. World Journal of Gastroenterology 2004; 10(6): 813-818 doi: 10.3748/wjg.v10.i6.813
|
| 69 |
Rafael Uribarrena A, Javier Ortego, Javier Fuentes, Nuria Raventós, Pilar Parra, Rafael Uribarrena E. Prognostic Value of Microvascular Density in Dukes A and B (T1–T4, N0, M0) Colorectal Carcinomas. Gastroenterology Research and Practice 2009; 2009: 1 doi: 10.1155/2009/679830
|